Holdings of Ally Bridge Group (NY) LLC
18 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 73.5 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 84.3 %
- FR 9.1 %
- GB 6.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 15 | 73.3M $ | 84.28 % |
| 2 | FR | 2 | 7.9M $ | 9.07 % |
| 3 | GB | 1 | 5.8M $ | 6.64 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Praxis Precision Medicines Inc | 32,810 | 10.6M $ | |
| 2 | Minerva Neurosciences Inc | 1,655,500 | 10M $ | |
| 3 | Soleno Therapeutics Inc | 200,000 | 6.7M $ | |
| 4 | Ovid therapeutics Inc | 2,818,459 | 6.3M $ | |
| 5 | Compass Pathways plc | 1,045,000 | 5.8M $ | |
| 6 | Tarsus Pharmaceuticals Inc | 80,859 | 5.7M $ | |
| 7 | Solid Biosciences Inc | 766,974 | 5.5M $ | |
| 8 | Edgewise Therapeutics Inc | 161,000 | 5.1M $ | |
| 9 | CytomX Therapeutics Inc | 900,000 | 4.2M $ | |
| 10 | Inventiva SACA | 745,300 | 4.1M $ | |
| 11 | Perspective Therapeutics Inc | 926,557 | 3.9M $ | |
| 12 | Abivax SA | 33,712 | 3.8M $ | |
| 13 | Alumis Inc | 166,959 | 3.7M $ | |
| 14 | Capricor Therapeutics Inc | 113,899 | 3.5M $ | |
| 15 | Aadi Bioscience Inc | 817,939 | 2.8M $ | |
| 16 | Inhibikase Therapeutics Inc | 1,325,000 | 2.2M $ | |
| 17 | AN2 Therapeutics Inc | 526,315 | 1.8M $ | |
| 18 | Relmada Therapeutics Inc | 210,525 | 1.5M $ |